bioAffinity Technologies Advances CyPath® Lung Test for Post-Treatment Lung Cancer Surveillance

Filing content

bioAffinity Technologies announced it is advancing the potential application of its CyPath® Lung test for the surveillance of lung cancer patients who have completed treatment.